» Articles » PMID: 15539444

ESHRE PGD Consortium 'Best Practice Guidelines for Clinical Preimplantation Genetic Diagnosis (PGD) and Preimplantation Genetic Screening (PGS)'

Overview
Journal Hum Reprod
Date 2004 Nov 13
PMID 15539444
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Among the many educational materials produced by the European Society of Human Reproduction and Embryology (ESHRE) are guidelines. ESHRE guidelines may be developed for many reasons but their intent is always to promote best quality practices in reproductive medicine. In an era in which preimplantation genetic diagnosis (PGD) has become a reality, we must strive to maintain its efficacy and credibility by offering the safest and most effective treatment available. The dominant motivators for the development of current comprehensive guidelines for best PGD practice were (i) the absence of guidelines and/or regulation for PGD in many countries and (ii) the observation that no consensus exists on many of the clinical and technical aspects of PGD. As a consequence, the ESHRE PGD Consortium undertook to draw up guidelines aimed at giving information, support and guidance to potential, fledgling and established PGD centres. The success of a PGD treatment cycle is the result of great attention to detail. We have strived to provide a similar level of detail in this document and hope that it will assist staff in achieving the best clinical outcome for their patients.

Citing Articles

Decade-long application of preimplantation genetic testing for DMD/BMD: analysis of five clinical strategies and embryo recombination patterns.

Wang W, Dai J, Hu X, He W, Gu Y, Wan Z Hum Genet. 2025; .

PMID: 39969580 DOI: 10.1007/s00439-025-02728-y.


Preimplantation Genetic Testing (PGT) to Reduce the Risk for GBA-Related Parkinson's Disease: Expanding the Applications for Embryo Selection.

Zuckerman S, Zimran A, Szer J, Revel-Vilk S, Altarescu G Int J Mol Sci. 2025; 26(3).

PMID: 39940681 PMC: 11817231. DOI: 10.3390/ijms26030912.


A method for determining potential parental contamination: linkage disequilibrium-based log-likelihood ratio analysis for IVF-PGT.

Bo L, Dong F, Wu Z, Zhou A, Zhang Y, Kong L Reprod Biol Endocrinol. 2024; 22(1):129.

PMID: 39434113 PMC: 11492770. DOI: 10.1186/s12958-024-01300-z.


Pregnancy rate and time to pregnancy after recurrent implantation failure (RIF)-a prospective cohort follow-up study.

Stevens Brentjens L, Roumen R, Smits L, Derhaag J, Romano A, van Golde R J Assist Reprod Genet. 2024; 41(11):3061-3070.

PMID: 39349892 PMC: 11621263. DOI: 10.1007/s10815-024-03257-9.


Efficacy of intrauterine autologous blood cell derivatives in enhancing endometrial thickness and IVF outcomes for women with recurrent implantation failure: a retrospective cohort study.

Tiwari S, Poojari V, Mundkur A, Adiga P, Kumar P, Bhatele P J Assist Reprod Genet. 2024; 41(10):2667-2680.

PMID: 39235518 PMC: 11535134. DOI: 10.1007/s10815-024-03231-5.